X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2247) 2247
indans - therapeutic use (2056) 2056
male (1479) 1479
piperidines - therapeutic use (1428) 1428
female (1159) 1159
aged (1069) 1069
cholinesterase inhibitors - therapeutic use (1024) 1024
alzheimer disease - drug therapy (995) 995
donepezil (914) 914
indans - pharmacology (674) 674
animals (663) 663
middle aged (646) 646
alzheimer's disease (625) 625
treatment outcome (607) 607
pharmacology & pharmacy (596) 596
nootropic agents - therapeutic use (533) 533
clinical neurology (522) 522
indans - adverse effects (504) 504
double-blind (501) 501
dementia (499) 499
aged, 80 and over (473) 473
psychiatry (457) 457
neurosciences (449) 449
indans - administration & dosage (418) 418
alzheimers-disease (396) 396
rivastigmine (374) 374
double-blind method (354) 354
rats (330) 330
piperidines - pharmacology (321) 321
piperidines - adverse effects (310) 310
dose-response relationship, drug (306) 306
adult (304) 304
efficacy (300) 300
geriatrics & gerontology (286) 286
drug therapy (274) 274
neuropsychological tests (267) 267
cholinesterase inhibitors - pharmacology (254) 254
cholinesterase inhibitors - adverse effects (242) 242
galantamine - therapeutic use (229) 229
time factors (227) 227
severity of illness index (224) 224
parkinson disease - drug therapy (214) 214
alzheimer disease - psychology (211) 211
cholinesterase inhibitors (209) 209
piperidines - administration & dosage (204) 204
mice (202) 202
cognition disorders - drug therapy (201) 201
placebo-controlled trial (195) 195
safety (194) 194
drug therapy, combination (193) 193
neuroprotective agents - therapeutic use (184) 184
pulmonary disease, chronic obstructive - drug therapy (182) 182
parkinson's disease (178) 178
phenylcarbamates - therapeutic use (175) 175
randomized controlled trials as topic (174) 174
analysis (170) 170
neurology (168) 168
memantine - therapeutic use (165) 165
alzheimers disease (162) 162
cognition - drug effects (162) 162
cholinesterase-inhibitors (161) 161
dementia - drug therapy (157) 157
medicine, general & internal (156) 156
cognition (155) 155
clinical trials as topic (154) 154
cholinesterase inhibitors - administration & dosage (153) 153
quinolones - therapeutic use (151) 151
gerontology (150) 150
rasagiline (148) 148
alzheimer disease - diagnosis (147) 147
care and treatment (144) 144
galantamine (142) 142
memory (141) 141
indans - pharmacokinetics (140) 140
disease models, animal (135) 135
disease progression (130) 130
research (129) 129
indans - chemistry (127) 127
rats, sprague-dawley (126) 126
monoamine oxidase inhibitors - therapeutic use (120) 120
alzheimer disease - physiopathology (118) 118
clinical trials (118) 118
nootropic agents - adverse effects (118) 118
therapy (118) 118
memantine (117) 117
medicine & public health (116) 116
respiratory system (115) 115
activities of daily living (114) 114
indacaterol (114) 114
bronchodilator agents - therapeutic use (112) 112
brain (111) 111
pharmacology/toxicology (110) 110
drug administration schedule (109) 109
acetylcholinesterase (107) 107
moderate (104) 104
neuroprotection (101) 101
brain - drug effects (100) 100
quinolones - administration & dosage (100) 100
follow-up studies (99) 99
diagnosis (97) 97
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2513) 2513
Japanese (72) 72
German (45) 45
French (32) 32
Spanish (27) 27
Russian (18) 18
Chinese (12) 12
Danish (7) 7
Polish (5) 5
Hungarian (4) 4
Italian (3) 3
Ukrainian (3) 3
Dutch (2) 2
Romanian (2) 2
Finnish (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC pulmonary medicine, ISSN 1471-2466, 2015, Volume 15, Issue 1, p. 145
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2018, Volume 198, Issue 3, pp. 329 - 339
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 23, pp. 2222 - 2234
Journal Article
Cold Spring Harbor perspectives in medicine, ISSN 2157-1422, 2011, Volume 2, Issue 3, pp. a006395 - a006395
Journal Article
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 2013, Volume 1, Issue 1, pp. 51 - 60
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2018, Volume 319, Issue 2, pp. 130 - 142
IMPORTANCE: New therapeutic approaches for Alzheimer disease (AD) are needed. OBJECTIVE: To assess whether idalopirdine, a selective 5-hydroxytryptamine-6 receptor antagonist, is effective for symptomatic treatment of mild to moderate AD... 
DONEPEZIL | 5-HT6 RECEPTOR ANTAGONIST | MODERATE | MEDICINE, GENERAL & INTERNAL | DOUBLE-BLIND | SEROTONIN | SB-742457 | RATING-SCALE | VALIDITY | Serotonin Antagonists - administration & dosage | Benzylamines - adverse effects | Humans | Middle Aged | Male | Indans - therapeutic use | Benzylamines - administration & dosage | Indoles - administration & dosage | Dose-Response Relationship, Drug | Serotonin Antagonists - adverse effects | Treatment Failure | Aged, 80 and over | Female | Drug Therapy, Combination | Accidental Falls | Alzheimer Disease - psychology | Double-Blind Method | Alzheimer Disease - drug therapy | Serotonin Antagonists - therapeutic use | Cognition - drug effects | Indoles - adverse effects | Galantamine - therapeutic use | Piperidines - therapeutic use | Cholinesterase Inhibitors - adverse effects | Indoles - therapeutic use | Aged | Rivastigmine - therapeutic use | Cholinesterase Inhibitors - therapeutic use | Benzylamines - therapeutic use | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Clinical trials | Dosage and administration | Cholinesterase inhibitors | Alzheimer's disease | Drugs | Medical research | Activities of daily living | Galantamine | Neurodegenerative diseases | Serotonin | Medical treatment | Cognitive ability | Cognition | Patients | Cholinesterase | Randomization | Safety engineering | Donepezil | Alzheimers disease | Original Investigation | Research
Journal Article
Journal Article
Book Chapter
Current Opinion in Pulmonary Medicine, ISSN 1070-5287, 03/2018, Volume 24, Issue 2, pp. 130 - 137
PURPOSE OF REVIEWRecent updates to the GOLD guidelines emphasize the use of combination LABA and LAMA bronchodilators for patients with chronic obstructive pulmonary disease with persistent dyspnea... 
Long-Acting muscarinic antagonists | Chronic obstructive pulmonary disease | Long-Acting beta agonists | Bronchodilator | CO-SUSPENSION(TM) DELIVERY TECHNOLOGY | long-acting beta agonists | LUNG-FUNCTION | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL-FLUTICASONE | ONCE-DAILY TIOTROPIUM | ACLIDINIUM BROMIDE | TO-SEVERE COPD | RESPIRATORY SYSTEM | LONG-TERM SAFETY | PARALLEL-GROUP | DOUBLE-BLIND | bronchodilator | chronic obstructive pulmonary disease | long-acting muscarinic antagonists | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - therapeutic use | Benzyl Alcohols - therapeutic use | Indans - therapeutic use | Quinuclidines - therapeutic use | Tiotropium Bromide - administration & dosage | Quinolones - therapeutic use | Tiotropium Bromide - therapeutic use | Indans - administration & dosage | Formoterol Fumarate - therapeutic use | Benzoxazines - administration & dosage | Glycopyrrolate - therapeutic use | Administration, Inhalation | Tropanes - therapeutic use | Benzoxazines - therapeutic use | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Chlorobenzenes - therapeutic use | Delayed-Action Preparations | Drug Combinations | Practice Guidelines as Topic | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Dosage and administration | Safety and security measures | Research | Drug therapy | Bronchodilator agents
Journal Article
Advances in Therapy, ISSN 0741-238X, 3/2019, Volume 36, Issue 3, pp. 495 - 519
...; regional guidelines such as the Japanese and Korean guidelines also provide similar recommendations for the use of LABA/LAMA FDCs... 
Indacaterol/glycopyrronium | Rheumatology | Internal Medicine | Oncology | Olodaterol/tiotropium | Medicine & Public Health | Asia | Fixed-dose combination | Formoterol/aclidinium | Vilanterol/umeclidinium | Long-acting muscarinic antagonists | Long-acting β-agonists | Chronic obstructive pulmonary disease | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | Long-acting beta-agonists | PHARMACOLOGICAL CHARACTERIZATION | QVA149 INDACATEROL/GLYCOPYRRONIUM | OBSTRUCTIVE PULMONARY-DISEASE | ACLIDINIUM BROMIDE | 5 MU-G | ONCE-DAILY INDACATEROL | TWICE-DAILY SALMETEROL | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | JAPANESE PATIENTS | CHINESE PATIENTS | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - adverse effects | Muscarinic Antagonists - therapeutic use | Benzyl Alcohols - therapeutic use | Indans - therapeutic use | Quinuclidines - therapeutic use | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Tiotropium Bromide - therapeutic use | Bronchodilator Agents - adverse effects | Formoterol Fumarate - therapeutic use | Glycopyrrolate - therapeutic use | Administration, Inhalation | Treatment Outcome | Tropanes - therapeutic use | Benzoxazines - therapeutic use | Muscarinic Antagonists - administration & dosage | Asian Continental Ancestry Group | Chlorobenzenes - therapeutic use | Adrenergic beta-2 Receptor Agonists - administration & dosage | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | aclidinium | umeclidinium | Indacaterol | Review | tiotropium | Vilanterol | Formoterol | glycopyrronium | Olodaterol
Journal Article